Riskpilot← Back to searchSign inGet full accessASKER DYREKLINIKK AS
ASActiveOrg 994311808Hvalstadveien 41, 1395 HvalstadVeterinary activities · NACE 7500Est. 200917 employees
Revenue 2021
NOK 15,4M
+21% vs 2020
EBITDA margin
23.1%
+52% vs 2020
Equity ratio
43.4%
Financial strength
Net profit 2021
NOK 2,7M
+46% vs 2020
| Revenue | NOK 15,4M | +21% |
| EBITDA | NOK 3,6M | +52% |
| Net profit | NOK 2,7M | +46% |
| Total assets | NOK 6,3M | +35% |
| Equity | NOK 2,7M | +85% |
| Employees | 17 | — |
Legal name
ASKER DYREKLINIKK AS
Org number
994311808
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
15. juli 2009
Share capital
NOK 5 000 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Dyreklinikk, samt kjøp og salg av dyreprodukter.
Address
Hvalstadveien 41, 1395 Hvalstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10 784 | 11 177 | 11 515 | 12 674 | 15 371 |
| Staff expenses | −4 712 | −5 489 | −5 467 | −5 422 | −6 199 |
| EBITDA | 1 590 | 1 240 | 1 565 | 2 331 | 3 551 |
| Depreciation & amort. | −366 | −150 | −161 | −164 | −131 |
| EBIT | 1 224 | 1 090 | 1 405 | 2 168 | 3 420 |
| Net financials | 1 | 1 | 4 | 5 | −1 |
| Profit before tax | 1 225 | 1 091 | 1 408 | 2 173 | 3 419 |
| Tax | 313 | 259 | 444 | 354 | 761 |
| Net profit | 912 | 832 | 965 | 1 819 | 2 658 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3 600 | 3 375 | 3 491 | 4 671 | 6 291 |
| Equity | 209 | 191 | 555 | 1 474 | 2 732 |
| Long-term debt | 450 | 330 | 210 | 0 | 0 |
| Short-term debt | 2 941 | 2 854 | 2 726 | 3 197 | 3 559 |
| Total debt | 3 391 | 3 184 | 2 936 | 3 197 | 3 559 |
EBITDA margin
23.1%
This company
15.8%
Market median
+46% vs market
20172021
Equity ratio
43.4%
This company
38.2%
Market median
+14% vs market
20172021
Return on equity
97.3%
This company
18.4%
Market median
+429% vs market
20172021
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
20172021
Asset turnover
2.44×
This company
1.12×
Market median
+118% vs market
20172021
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HS Deputy Member | Deputy Member | 2009 |
HG Chief Executive Officer | Chief Executive Officer | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2009 | |
| Chairman | 2009 | |
| Deputy Chairman | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASKER DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hein Stigum | Deputy Member | 0 companies |
| Hulda Gudmundsdottir | Chief Executive Officer | 0 companies |
| Karin Michaela Andersen | Board of Directors | 0 companies |
| Tor Agnar Osmundsen | Chairman | 0 companies |
| Toril Malmer | Deputy Chairman | 0 companies |